MEDS logo

TRxADE HEALTH (MEDS) Cash From Operations

Annual CFO

-$2.07 M
-$508.90 K-32.52%

December 31, 2023

Summary

Performance

1-Year Change

-32.52%

3-Year Change

+6.38%

5-Year Change

-858.45%

15-Year Change

-1307.69%

MEDS Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$273.40 K
MEDS annual cash flow from operations is currently -858.45% below its historical high of $273.40 thousand

3-Year Low

-$2.57 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MEDS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
MEDS next annual earnings announcement has not yet been scheduled

OtherMEDScash flowmetrics:

Annual CFI

-$275.70 K
MEDS annual cash flow from investing activities is -$275.70 thousand

Annual CFF

$1.41 M
MEDS annual cash flow from financing activities is $1.41 million

Annual FCF

-$2.07 M
MEDS annual free cash flow is -$2.07 million

Annual CAPEX

-
MEDS annual capital expenditures value is unknown

Quarterly CFO

-$5.39 M
-$9.61 M-227.60%

September 30, 2024

Summary

Performance

3-Month Change

-227.6%

1-Year Change

+47.13%

3-Year Change

-629.88%

5-Year Change

-1432.49%

MEDS Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.22 M
MEDS quarterly cash flow from operations is currently -227.60% below its historical high of $4.22 million

3-Year Low

-$10.19 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MEDS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
MEDS next earnings announcement has not yet been scheduled

OtherMEDScash flowmetrics:

Quarterly CFI

$120.98 K
MEDS quarterly cash flow from investing activities is $120.98 thousand

Quarterly CFF

-$1.87 M
MEDS quarterly cash flow from financing activities is -$1.87 million

Quarterly FCF

-$5.40 M
MEDS quarterly free cash flow is -$5.40 million

Quarterly CAPEX

-
MEDS quarterly capital expenditures value is unknown

TTM CFO

-$12.22 M
-$4.78 M-64.32%

September 30, 2024

Summary

Performance

3-Month Change

-64.32%

1-Year Change

-7.86%

3-Year Change

-328.11%

5-Year Change

-8719.51%

MEDS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$366.70 K
MEDS TTM cash flow from operations is currently -3433.10% below its historical high of $366.70 thousand

3-Year Low

-$12.22 M
MEDS TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MEDS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
MEDS next earnings announcement has not yet been scheduled

OtherMEDScash flowmetrics:

TTM CFI

$27.20 M
MEDS TTM cash flow from investing activities is $27.20 million

TTM CFF

-$14.43 M
MEDS TTM cash flow from financing activities is -$14.43 million

TTM FCF

-$12.24 M
MEDS TTM free cash flow is -$12.24 million

TTM CAPEX

-
MEDS TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

MEDS Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-32.5%+47.1%-7.9%
3 y3 years+6.4%-629.9%-328.1%
5 y5 years-858.5%-1432.5%-8719.5%

MEDS Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+32.5%+23.8%-227.6%+89.1%<-9999.0%at low
5 y5-year-1562.3%+23.8%-227.6%+89.1%-3434.9%at low
alltimeall time-858.4%+1258.2%-227.6%+422.4%-3433.1%+130.5%

TRxADE HEALTH Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.39 M(-227.6%)
-$12.22 M(+64.3%)
Jun 2024
-
$4.22 M(-141.4%)
-$7.44 M(-34.4%)
Mar 2024
-
-$10.19 M(+1074.6%)
-$11.33 M(+446.5%)
Dec 2023
-$2.07 M(+32.5%)
-$867.50 K(+43.8%)
-$2.07 M(>+9900.0%)
Sep 2023
-
-$603.10 K(-283.5%)
-$14.70 K(-227.8%)
Jun 2023
-
$328.60 K(-135.3%)
$11.50 K(-100.8%)
Mar 2023
-
-$931.50 K(-178.2%)
-$1.50 M(-4.4%)
Dec 2022
-$1.56 M(-39.0%)
$1.19 M(-306.5%)
-$1.56 M(-50.8%)
Sep 2022
-
-$576.90 K(-51.0%)
-$3.18 M(-4.8%)
Jun 2022
-
-$1.18 M(+17.7%)
-$3.34 M(+17.1%)
Mar 2022
-
-$1.00 M(+134.5%)
-$2.86 M(+11.3%)
Dec 2021
-$2.57 M(+15.9%)
-$426.70 K(-42.2%)
-$2.57 M(-10.1%)
Sep 2021
-
-$738.10 K(+6.8%)
-$2.85 M(-879.0%)
Jun 2021
-
-$691.10 K(-2.7%)
$366.50 K(-114.6%)
Mar 2021
-
-$710.30 K(-0.7%)
-$2.51 M(+13.5%)
Dec 2020
-$2.21 M(-1661.9%)
-$715.50 K(-128.8%)
-$2.21 M(+31.7%)
Sep 2020
-
$2.48 M(-169.5%)
-$1.68 M(-55.3%)
Jun 2020
-
-$3.57 M(+769.5%)
-$3.76 M(+2526.5%)
Mar 2020
-
-$410.80 K(+124.7%)
-$143.20 K(-201.0%)
Dec 2019
$141.80 K(-48.1%)
-$182.80 K(-145.2%)
$141.80 K(-61.3%)
Sep 2019
-
$404.30 K(+777.0%)
$366.70 K(+675.3%)
Jun 2019
-
$46.10 K(-136.6%)
$47.30 K(-41.6%)
Mar 2019
-
-$125.80 K(-398.8%)
$81.00 K(-70.4%)
Dec 2018
$273.40 K(+59.2%)
$42.10 K(-50.4%)
$273.50 K(-3.9%)
Sep 2018
-
$84.90 K(+6.4%)
$284.70 K(-10.1%)
Jun 2018
-
$79.80 K(+19.6%)
$316.60 K(+10.4%)
Mar 2018
-
$66.70 K(+25.1%)
$286.70 K(+67.0%)
Dec 2017
$171.70 K
$53.30 K(-54.4%)
$171.70 K(-134.9%)
DateAnnualQuarterlyTTM
Sep 2017
-
$116.80 K(+134.1%)
-$491.90 K(-48.5%)
Jun 2017
-
$49.90 K(-203.3%)
-$955.80 K(-25.3%)
Mar 2017
-
-$48.30 K(-92.1%)
-$1.28 M(-2.6%)
Dec 2016
-$1.31 M(-33.5%)
-$610.30 K(+75.8%)
-$1.31 M(-30.5%)
Sep 2016
-
-$347.10 K(+26.7%)
-$1.89 M(+15.8%)
Jun 2016
-
-$274.00 K(+234.1%)
-$1.63 M(-3.1%)
Mar 2016
-
-$82.00 K(-93.1%)
-$1.69 M(-14.6%)
Dec 2015
-$1.97 M(+85.4%)
-$1.19 M(+1227.2%)
-$1.97 M(+71.5%)
Sep 2015
-
-$89.50 K(-72.6%)
-$1.15 M(-14.6%)
Jun 2015
-
-$326.10 K(-11.9%)
-$1.35 M(+13.7%)
Mar 2015
-
-$370.30 K(+1.4%)
-$1.19 M(+11.4%)
Dec 2014
-$1.06 M(+26.0%)
-$365.20 K(+27.3%)
-$1.06 M(+52.2%)
Sep 2014
-
-$286.90 K(+75.9%)
-$699.40 K(+69.6%)
Jun 2014
-
-$163.10 K(-34.6%)
-$412.50 K(+65.4%)
Mar 2014
-
-$249.40 K(>+9900.0%)
-$249.40 K(-99.1%)
Dec 2013
-$844.60 K(-97.0%)
-
-
Sep 2009
-
-$1500.00(+650.0%)
-$28.15 M(+0.0%)
Jun 2009
-
-$200.00(-98.0%)
-$28.15 M(-0.1%)
Mar 2009
-
-$9900.00(-100.0%)
-$28.17 M(+0.0%)
Dec 2008
-$28.16 M(>+9900.0%)
-$28.14 M(>+9900.0%)
-$28.16 M(>+9900.0%)
Sep 2008
-
-$500.00(-97.4%)
-$26.10 K(-19.2%)
Jun 2008
-
-$19.20 K(+1645.5%)
-$32.30 K(+90.0%)
Mar 2008
-
-$1100.00(-79.2%)
-$17.00 K(+6.3%)
Dec 2007
-$16.10 K(+159.7%)
-$5300.00(-20.9%)
-$16.00 K(+49.5%)
Sep 2007
-
-$6700.00(+71.8%)
-$10.70 K(+167.5%)
Jun 2007
-
-$3900.00(+3800.0%)
-$4000.00(+3900.0%)
Mar 2007
-
-$100.00
-$100.00
Dec 2006
-$6200.00
-
-

FAQ

  • What is TRxADE HEALTH annual cash flow from operations?
  • What is the all time high annual CFO for TRxADE HEALTH?
  • What is TRxADE HEALTH annual CFO year-on-year change?
  • What is TRxADE HEALTH quarterly cash flow from operations?
  • What is the all time high quarterly CFO for TRxADE HEALTH?
  • What is TRxADE HEALTH quarterly CFO year-on-year change?
  • What is TRxADE HEALTH TTM cash flow from operations?
  • What is the all time high TTM CFO for TRxADE HEALTH?
  • What is TRxADE HEALTH TTM CFO year-on-year change?

What is TRxADE HEALTH annual cash flow from operations?

The current annual CFO of MEDS is -$2.07 M

What is the all time high annual CFO for TRxADE HEALTH?

TRxADE HEALTH all-time high annual cash flow from operations is $273.40 K

What is TRxADE HEALTH annual CFO year-on-year change?

Over the past year, MEDS annual cash flow from operations has changed by -$508.90 K (-32.52%)

What is TRxADE HEALTH quarterly cash flow from operations?

The current quarterly CFO of MEDS is -$5.39 M

What is the all time high quarterly CFO for TRxADE HEALTH?

TRxADE HEALTH all-time high quarterly cash flow from operations is $4.22 M

What is TRxADE HEALTH quarterly CFO year-on-year change?

Over the past year, MEDS quarterly cash flow from operations has changed by +$4.80 M (+47.13%)

What is TRxADE HEALTH TTM cash flow from operations?

The current TTM CFO of MEDS is -$12.22 M

What is the all time high TTM CFO for TRxADE HEALTH?

TRxADE HEALTH all-time high TTM cash flow from operations is $366.70 K

What is TRxADE HEALTH TTM CFO year-on-year change?

Over the past year, MEDS TTM cash flow from operations has changed by -$890.76 K (-7.86%)